BOSTON - NMT Medical, Inc. has received Pre-Market Approval from the US Food and Drug Administration for the sale of its STARFlex cardiac septal repair implant in the United States for patients with ventricular septal defects (VSD), an opening between the right and left ventricle in the lower chambers of the heart.

Why Subscribe?

Interested in advertising?

Simply give us a call

Sales: +44 1977 708488

Or if you prefer email, click on the button below and we'll get back to you asap